BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,717 | +1526.3% | 213,409 | +1946.3% | 0.10% | +1940.0% |
| Q2 2023 | $659 | -95.5% | 10,429 | -96.8% | 0.01% | -95.9% |
| Q1 2023 | $14,750 | +114.0% | 327,859 | +108.3% | 0.12% | +22.0% |
| Q4 2022 | $6,894 | -99.2% | 157,367 | +826.3% | 0.10% | +809.1% |
| Q2 2022 | $858,000 | -70.8% | 16,988 | -35.1% | 0.01% | -62.1% |
| Q4 2020 | $2,936,000 | +292.5% | 26,181 | +224.3% | 0.03% | +93.3% |
| Q3 2020 | $748,000 | +156.2% | 8,074 | +115.9% | 0.02% | +87.5% |
| Q2 2020 | $292,000 | – | 3,740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |